Larvol Delta - PEPN2111-CBL0137-for-the-Treatment-of-Relapsed-or-Refractory-Solid-Tumors-Including-CNS-Tumors-and-Lymphoma

CBL0137 - Incuron, Children's Oncology Group

http://clinicaltrials.gov/ct2/show/NCT04870944

Aug 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next